Todays high of $1.84, now $1.75 and a big increase in shares gone through and you think nobody expected news on dosing....I think a lot of people were hoping on news.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
